Abiopharma

New Form SCHEDULE 13G/A - ANGIODYNAMICS INC Filed: 2026-01-08 AccNo: 0001104659-26-002149 Size: 18 KB

📋 Roberts Evan (Officer) plans to sell 6K shares of Phreesia, Inc. (at $17.01 each, total $107K) Filed: Jan 08, 2026 | ID: 000226

Novel Inspiration International Co., Ltd. 🟢 acquired 97.6K shares of IRIDEX CORP (IRIX) Transaction Date: Oct 01, 2025 | Filing ID: 000010

📋 OConnell Daniel Joseph (Officer) plans to sell 8K shares of Acumen Pharmaceuticals, Inc. (at $1.82 each, total $15K) Filed: Jan 08, 2026 | ID: 000023

Illumina, Inc. - Illumina Appoints Dr. Eric Green as Chief Medical Officer

Novel Inspiration International Co., Ltd. 🟢 acquired 137.3K shares of IRIDEX CORP (IRIX) Transaction Date: Jul 01, 2025 | Filing ID: 000009

New Form 3 - IRIDEX CORP Filed: 2026-01-08 AccNo: 0002097627-26-000008 Size: 8 KB

New Form SCHEDULE 13D/A - Mersana Therapeutics, Inc. Filed: 2026-01-08 AccNo: 0001193125-26-007752 Size: 11 KB

Cavalier Jason 🔴 sold 769 shares of Lyra Therapeutics, Inc. (LYRA) at $3.36 Transaction Date: Jan 06, 2026 | Filing ID: 007760

Palasis Maria 🔴 sold 1.7K shares of Lyra Therapeutics, Inc. (LYRA) at $3.36 Transaction Date: Jan 06, 2026 | Filing ID: 007751

Cellectis Announces 2026 Strategy and Catalysts

Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026

Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

📋 Almstead Zheng Yang (Member of immediate family of any of the foregoing) plans to sell 59 shares of PTC THERAPEUTICS, INC. (at $76.45 each, total $5K) Filed: Jan 08, 2026 | ID: 000225